IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Provectus Biopharmaceuticals,

CUSIP: 74373F100 | 9 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

Vantage Investment Advisors, LLC1,318
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vantage Investment Advisors, LLC
1,318$00.0%N/AN/AState College, PA2018-05-10